No Data
No Data
Express News | Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024
Navidea Biopharmaceuticals, Inc. Announces Special Meeting of Stockholders to Be Held July 8, 2024
Navidea Biopharmaceucitals, Inc. will present two proposals for vote in a virtual special meeting of shareholders to be held on July 8, 2024COLUMBUS, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals,
Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend Its SEC Reporting Obligations
Navidea Biopharmaceuticals, Inc. announced today the filing of Form 15 to voluntarily deregister and suspend SEC reporting obligations. The company maintains strategic focus on its Fix, Fund, Propel a
Navidea Settles Litigation With Capital Royalty, Stock Rallies 30%
Navidea Biopharmaceuticals, CRG Settle All Ongoing Litigation
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. have entered into a binding settlement agreement and mutual release settling ongoing litigation.DUBLIN, Ohio--(BUSINESS WIRE)--Na
No Data